Chen-Meng Qiao

1.5k total citations
35 papers, 1.2k citations indexed

About

Chen-Meng Qiao is a scholar working on Molecular Biology, Neurology and Neurology. According to data from OpenAlex, Chen-Meng Qiao has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Neurology and 10 papers in Neurology. Recurrent topics in Chen-Meng Qiao's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Neuroinflammation and Neurodegeneration Mechanisms (9 papers) and Gut microbiota and health (6 papers). Chen-Meng Qiao is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Neuroinflammation and Neurodegeneration Mechanisms (9 papers) and Gut microbiota and health (6 papers). Chen-Meng Qiao collaborates with scholars based in China. Chen-Meng Qiao's co-authors include Chun Cui, Yan‐Qin Shen, Liping Zhao, Xin Zhang, Xue-Bing Jia, Jun Yang, Jie Weng, Zhi-Lan Zhou, Mengfei Sun and Bo-Ping Zhang and has published in prestigious journals such as Advanced Materials, Biomaterials and Biochemical and Biophysical Research Communications.

In The Last Decade

Chen-Meng Qiao

34 papers receiving 1.1k citations

Peers

Chen-Meng Qiao
Behnam Noorani United States
Buddhadev Layek United States
Akihiko Urayama United States
Siva P. Kambhampati United States
Anjali Sharma United States
Stephanie Tran United States
Behnam Noorani United States
Chen-Meng Qiao
Citations per year, relative to Chen-Meng Qiao Chen-Meng Qiao (= 1×) peers Behnam Noorani

Countries citing papers authored by Chen-Meng Qiao

Since Specialization
Citations

This map shows the geographic impact of Chen-Meng Qiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen-Meng Qiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen-Meng Qiao more than expected).

Fields of papers citing papers by Chen-Meng Qiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen-Meng Qiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen-Meng Qiao. The network helps show where Chen-Meng Qiao may publish in the future.

Co-authorship network of co-authors of Chen-Meng Qiao

This figure shows the co-authorship network connecting the top 25 collaborators of Chen-Meng Qiao. A scholar is included among the top collaborators of Chen-Meng Qiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen-Meng Qiao. Chen-Meng Qiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiao, Chen-Meng, Xiaoyu Ma, Lulu Tan, et al.. (2025). Indoleamine 2, 3-dioxygenase 1 inhibition mediates the therapeutic effects in Parkinson's disease mice by modulating inflammation and neurogenesis in a gut microbiota dependent manner. Experimental Neurology. 385. 115142–115142. 6 indexed citations
2.
Zhang, Wei, Chong Liu, Qian Li, et al.. (2025). Targeted ErbB4 receptor activation prevents D-galactose-induced neuronal senescence via inhibiting ferroptosis pathway. Frontiers in Pharmacology. 16. 1528604–1528604. 3 indexed citations
4.
Wu, Jian, Wenyan Huang, Shengyang Zhou, et al.. (2025). Gut microbiota promote the propagation of pathologic α-syn from gut to brain in a gut-originated mouse model of Parkinson’s disease. Brain Behavior and Immunity. 128. 152–169. 4 indexed citations
6.
Zhang, Wei, Qian Li, Chong Liu, et al.. (2024). Neuregulin 1 mitigated prolactin deficiency through enhancing TRPM8 signaling under the influence of melatonin in senescent pituitary lactotrophs. International Journal of Biological Macromolecules. 275(Pt 1). 133659–133659. 2 indexed citations
7.
Qiao, Chen-Meng, Wenyan Huang, Yu Zhou, et al.. (2024). Akkermansia muciniphila Is Beneficial to a Mouse Model of Parkinson’s Disease, via Alleviated Neuroinflammation and Promoted Neurogenesis, with Involvement of SCFAs. Brain Sciences. 14(3). 238–238. 23 indexed citations
8.
Qiao, Chen-Meng, Lulu Tan, Xiaoyu Ma, et al.. (2024). Mechanism of S100A9-mediated astrocyte activation via TLR4/NF-κB in Parkinson’s disease. International Immunopharmacology. 146. 113938–113938. 6 indexed citations
9.
Cui, Chun, Yun Shi, Hui Hong, et al.. (2023). 5-HT4 Receptor is Protective for MPTP-induced Parkinson’s Disease Mice Via Altering Gastrointestinal Motility or Gut Microbiota. Journal of Neuroimmune Pharmacology. 18(4). 610–627. 9 indexed citations
10.
Quan, Wei, Chen-Meng Qiao, Jian Wu, et al.. (2023). Trimethylamine N-Oxide Exacerbates Neuroinflammation and Motor Dysfunction in an Acute MPTP Mice Model of Parkinson’s Disease. Brain Sciences. 13(5). 790–790. 24 indexed citations
11.
Zhao, Liping, Jian Wu, Yu Zhou, et al.. (2023). DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota. Frontiers in Immunology. 13. 1089200–1089200. 21 indexed citations
12.
Qiao, Chen-Meng, Weijiang Zhao, Wei Quan, et al.. (2023). RIPK1-Induced A1 Reactive Astrocytes in Brain in MPTP-Treated Murine Model of Parkinson’s Disease. Brain Sciences. 13(5). 733–733. 5 indexed citations
13.
Cui, Chun, Hui Hong, Yun Shi, et al.. (2022). Vancomycin Pretreatment on MPTP-Induced Parkinson’s Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut. Journal of Neuroimmune Pharmacology. 18(1-2). 72–89. 36 indexed citations
14.
Zhao, Liping, Bo-Ping Zhang, Zhi-Lan Zhou, et al.. (2021). Insulin-Like Growth Factor-1 Enhances Motoneuron Survival and Inhibits Neuroinflammation After Spinal Cord Transection in Zebrafish. Cellular and Molecular Neurobiology. 42(5). 1373–1384. 9 indexed citations
15.
Zhou, Yu, Weijiang Zhao, Wei Quan, et al.. (2021). Dynamic changes of activated AHR in microglia and astrocytes in the substantia nigra-striatum system in an MPTP-induced Parkinson’s disease mouse model. Brain Research Bulletin. 176. 174–183. 19 indexed citations
16.
Shi, Yun, Chen-Meng Qiao, Yu Zhou, et al.. (2021). Protective effects of prucalopride in MPTP-induced Parkinson’s disease mice: Neurochemistry, motor function and gut barrier. Biochemical and Biophysical Research Communications. 556. 16–22. 6 indexed citations
17.
Qiao, Chen-Meng, Mengfei Sun, Xue-Bing Jia, et al.. (2020). Sodium Butyrate Exacerbates Parkinson’s Disease by Aggravating Neuroinflammation and Colonic Inflammation in MPTP-Induced Mice Model. Neurochemical Research. 45(9). 2128–2142. 72 indexed citations
18.
Zhu, Yingli, Mengfei Sun, Xue-Bing Jia, et al.. (2018). Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress. International Immunopharmacology. 66. 19–27. 41 indexed citations
19.
Qiao, Chen-Meng, Jun Yang, Lei Chen, Jie Weng, & Xin Zhang. (2017). Intracellular accumulation and immunological responses of lipid modified magnetic iron nanoparticles in mouse antigen processing cells. Biomaterials Science. 5(8). 1603–1611. 9 indexed citations
20.
Chen, Jingli, Jun Yang, Ruiyuan Liu, et al.. (2017). Dual-targeting Theranostic System with Mimicking Apoptosis to Promote Myocardial Infarction Repair via Modulation of Macrophages. Theranostics. 7(17). 4149–4167. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026